Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nikhil Lalwani Insider Profile
11 Followers
Nikhil Lalwani, PRESIDENT & CEO, Director at ANI Pharmaceuticals, holds 370.38K shares in ANI Pharmaceuticals (Ticker: ANIP).
Nikhil Lalwani ANI Pharmaceuticals (ANIP)PRESIDENT & CEO, Director
ANI Pharmaceuticals (ANIP)
PRESIDENT & CEO, Director
Ranked #19,823 out of 99,797 Corporate Insiders
Profitable Transactions
5 out of 5 Profitable Transactions
Average Return
+14.20%
Average return per transaction
Time Frame
Compare to
Insider Roles
PRESIDENT & CEO, Director
Roles that Nikhil Lalwani holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 23, 2022 - Mar 23, 2023
Return:+39.90%
The most profitable trade made by Nikhil Lalwani
Nikhil Lalwani's Trading History
List of latest transactions for each holding click on a transaction to see Nikhil Lalwani's performance on stock
You May Also Like
Nikhil Lalwani insider profile FAQ
What is the percentage of profitable transactions made by Nikhil Lalwani?
The percentage of profitable transactions made by Nikhil Lalwani is 100%.
What is the average return per transaction made by Nikhil Lalwani?
The average return per transaction made by Nikhil Lalwani is 14.20%.
What stocks does Nikhil Lalwani hold?
Nikhil Lalwani holds: ANIP stocks.
What was Nikhil Lalwani’s latest transaction?
Nikhil Lalwani latest transaction was an Uninformative Buy of $870.00K.
What was Nikhil Lalwani's most profitable transaction?
Nikhil Lalwani’s most profitable transaction was an Informative Buy of ANIP stock on March 23, 2022. The return on the trade was 39.90%.
What is Nikhil Lalwani's role in ANI Pharmaceuticals?
Nikhil Lalwani's role in ANI Pharmaceuticals is PRESIDENT & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.